In summary, the results presented here demonstrate for the first time infrequent FGFR3 mutations in Han Chinese patients with UCC including UBC, RPC and UC, which suggest racial disparities in the oncogenic pathway, genetic susceptibility and environment underlying the development of UCCs between Han Chinese and Western/European patients. This evidence concerns the gene FGFR3 and familial reactive perforating collagenosis.